Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuo-Sheng Fan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Brain, Behavior, and Immunity|May 4, 2026
Reduced dementia risk in middle-aged and older atopic dermatitis patients treated with dupilumab: A target trial emulationYi-Hsuan Fan, Kuo-Sheng Fan, Teng-Li Lin
Frontiers in Medicine|May 28, 2021
Increased Incidence of Total Knee Replacement Surgery in Patients With Psoriasis: A Secondary Cohort Analysis of a Nationwide, Population-Based Health Claims DatabaseMing-Chi Lu, Kuo-Sheng Fan, Chia-Wen Hsu, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2012
Intravitreal administration of bevacizumab in the treatment of choroidal metastasis in a patient with erlotinib-failed pulmonary adenocarcinomaChun-Liang Lai, Kuo-Sheng Fan, Yen-Hsien Lee, et al.
JAMA Dermatology|June 18, 2025
Psoriasis Risk in Patients With Atopic Dermatitis Treated With DupilumabTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
Journal of the American Academy of Dermatology|June 15, 2024
Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort studyTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
Plos Medicine|April 17, 2025
Cardiovascular disease risk in patients with psoriasis receiving biologics targeting TNF-α, IL-12/23, IL-17, and IL-23: A population-based retrospective cohort studyTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
Rheumatology (Oxford, England)|October 17, 2025
Psoriatic arthritis risk in psoriasis patients receiving anti-IL-23 vs anti-IL-17: comparison of drug classes and individual agentsTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 29, 2024
Dupilumab impact on psychiatric and sleep disorder risk reduction in atopic dermatitis: A population-based cohort studyTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
Clinical Pharmacology and Therapeutics|March 14, 2026
Real-World Safety of JAK Inhibitors in Skin Immune-Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort StudyTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
The Clinical Respiratory Journal|March 8, 2017
CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary diseaseHean Ooi, Li-Hsiou Chen, Yung-Lun Ni, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Brain, Behavior, and Immunity|May 4, 2026
Reduced dementia risk in middle-aged and older atopic dermatitis patients treated with dupilumab: A target trial emulationYi-Hsuan Fan, Kuo-Sheng Fan, Teng-Li Lin
Frontiers in Medicine|May 28, 2021
Increased Incidence of Total Knee Replacement Surgery in Patients With Psoriasis: A Secondary Cohort Analysis of a Nationwide, Population-Based Health Claims DatabaseMing-Chi Lu, Kuo-Sheng Fan, Chia-Wen Hsu, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2012
Intravitreal administration of bevacizumab in the treatment of choroidal metastasis in a patient with erlotinib-failed pulmonary adenocarcinomaChun-Liang Lai, Kuo-Sheng Fan, Yen-Hsien Lee, et al.
JAMA Dermatology|June 18, 2025
Psoriasis Risk in Patients With Atopic Dermatitis Treated With DupilumabTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
Journal of the American Academy of Dermatology|June 15, 2024
Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort studyTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
Plos Medicine|April 17, 2025
Cardiovascular disease risk in patients with psoriasis receiving biologics targeting TNF-α, IL-12/23, IL-17, and IL-23: A population-based retrospective cohort studyTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
Rheumatology (Oxford, England)|October 17, 2025
Psoriatic arthritis risk in psoriasis patients receiving anti-IL-23 vs anti-IL-17: comparison of drug classes and individual agentsTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 29, 2024
Dupilumab impact on psychiatric and sleep disorder risk reduction in atopic dermatitis: A population-based cohort studyTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
Clinical Pharmacology and Therapeutics|March 14, 2026
Real-World Safety of JAK Inhibitors in Skin Immune-Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort StudyTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
The Clinical Respiratory Journal|March 8, 2017
CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary diseaseHean Ooi, Li-Hsiou Chen, Yung-Lun Ni, et al.
Pageof 1